Quick Ref Guide

Background

• Viral respiratory infections are the most common cause of wheezing in infants and young children
• Risk factors include exposure to tobacco smoke and reduced lung function
• Although treatment is broadly like treatment for asthma there are some differences

Clinical Presentation

• Usually history runny nose, cough, intermittent fever then wheeze
• Only get wheezy with colds – no interval symptoms
• Examination – nasal congestion, tachypnoea, increased work of breathing and polyphonic wheeze.
• Assess for level of dehydration caused by tachypnoea, fever, decreased oral intake

What to do

• Assess severity:
• Hypoxia (<92%): give oxygenimmediately
• Life threatening: move to Resus and call for paediatric support – treat as BTS life threatening asthma
• Severe: use nebulised salbutamolin all age groups except under 6 months – refer to paediatrics
• Mild/Moderate: use inhaled salbutamol. If good response – can be discharged with viral wheeze plan (available on intranet). If poor response – consider treating as severe with nebulised bronchodilators

Other medications

• Ipratropium bromide– No evidence this is superior to salbutamol under 1 year – however can be added if no response to salbutamol
• Steroids– no evidence they reduce length of illness in mild to moderate casese – restrict to those who are very unwell and likely to need intensive care
• Antibiotics are not routinely used. However if indicated for suspected secondary bacterial infection / atypical pneumonia – Azithromycin is recommended for 3 days
• Prophylaxic Steroids – there is no strong evidence for any prophylaxis. High dose intermittent inhaled steroids has shown some improvement but cumulative dose risk outweighs benefits
• Montelukast – a small subgroup benefit and therefore trial may be appropriate

Discharge

• Complete Episodic Wheeze Plan
• Give advice sheet

 

Reference:

Guidance for the treatment of Episodic Viral Wheeze in Children (June 2018)